| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.16B | 20.46B | 19.09B | 17.74B | 16.23B | 14.85B |
| Gross Profit | 12.80B | 12.44B | 11.43B | 9.74B | 8.10B | 7.04B |
| EBITDA | 8.85B | 8.84B | 8.02B | 6.83B | 5.56B | 5.10B |
| Net Income | 3.61B | 3.13B | 3.07B | 2.53B | 1.33B | 958.00M |
Balance Sheet | ||||||
| Total Assets | 79.37B | 77.18B | 90.89B | 83.87B | 76.25B | 74.62B |
| Cash, Cash Equivalents and Short-Term Investments | 1.07B | 1.24B | 1.20B | 902.00M | 835.00M | 906.00M |
| Total Debt | 30.20B | 24.96B | 23.90B | 21.54B | 21.24B | 20.68B |
| Total Liabilities | 54.23B | 49.49B | 60.22B | 52.18B | 44.30B | 41.29B |
| Stockholders Equity | 25.12B | 27.07B | 29.86B | 30.83B | 30.95B | 32.33B |
Cash Flow | ||||||
| Free Cash Flow | 5.94B | 5.06B | 3.77B | 3.14B | 2.87B | 3.25B |
| Operating Cash Flow | 6.34B | 6.63B | 5.16B | 4.62B | 4.03B | 4.15B |
| Investing Cash Flow | -2.98B | -2.40B | -1.07B | -2.11B | -1.63B | -341.00M |
| Financing Cash Flow | -4.10B | -4.17B | -4.36B | -2.48B | -761.00M | -3.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $37.19B | 17.86 | 14.50% | 1.61% | 7.44% | -4.57% | |
77 Outperform | $12.59B | 26.42 | 23.45% | 1.39% | 7.75% | 20.42% | |
76 Outperform | $72.82B | 22.07 | 29.15% | 2.75% | 4.62% | 1.06% | |
74 Outperform | $29.24B | 17.92 | 16.39% | 3.07% | -1.97% | 48.61% | |
71 Outperform | $26.57B | 29.10 | 38.21% | 1.60% | 8.57% | 35.02% | |
68 Neutral | $32.70B | 9.40 | 13.64% | ― | 5.16% | 24.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |